IMM 1.45% 34.0¢ immutep limited

Ann: Efti with Keytruda shows encouraging activity in lung cancer, page-16

  1. 467 Posts.
    lightbulb Created with Sketch. 100
    My suspicion is that the very fund manager holding IMM are the one's leading to the shorts.

    I am frustrated and disappointed espically with the BMS FDA approval, I thought it would be a lot more in it for us....as i am sure is IMM management.

    I am sure Marc will work harder to get some action in this space...
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.